|
|
Long-Term Peginterferon Shows Promise Against Hepatitis B in Pilot Study
|
| Link ID |
1816 |
| Title |
Long-Term Peginterferon Shows Promise Against Hepatitis B in Pilot Study |
| Url |
http://www.medscape.com/viewarticle/567871?src=rss |
| Description |
Sixty weeks of treatment with pegylated interferon alfa-2a appears to produce a higher rate of sustained virologic response in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B than that usually achieved with the standard treatment duration of 48 weeks. The study is reported in the December issue of the American Journal of Gastroenterology. Reuters Health Information |
| Category |
Articles > Infectious Diseases |
| Keywords |
|
| Date |
Dec 22, 2007 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Infectious Diseases |
| 2. |
What Your Patients are Reading: Calcium Supplements May Increase MI Risk in Older Women
|
|
|
Recent news stories have examined links between calcium supplements and risk for MI, between the combination of ezetimibe and simvastatin and the statin alone, and between gay men and multidrug-resistant CA-MRSA, as well as studying the safety of meat from cloned meats animals, and the creation in a laboratory of a beating rat heart. Medscape Medical News
|
| 3. |
Five Lab Workers Exposed to Vaccinia in 2-Year Period
|
|
|
Recent reports of five laboratory-acquired vaccinia virus (VACV) infections underscore "the need for proper vaccination, laboratory safety, infection-control practices, and rapid medical evaluation of exposures in the context of orthopoxvirus research," Dr. R. Melchreit, from the Connecticut Department of Public Health, and associates write in the April 18th issue of the Morbidity and Mortality Weekly Report. Reuters Health Information
|
|
|
